In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Telix Pharmaceuticals Limited is one of them. Melbourne-based Telix Pharmaceuticals Limited (NASDAQ:TLX) is advancing its global footprint in precision oncology and targeted radiotherapies, with active clinical programs in prostate cancer and rare oncologic conditions. In its 2025 half-year update, the company reported a 30% revenue increase in its Precision Medicine segment, led by strong demand for its f ...

Cracker Barrel reported fourth-quarter revenue of $868.09 million, beating analyst estimates of $855.30 million, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of 74 cents per share, missing analyst estimates of 80 cents per share. "We thank our guests for sharing their voices and their passion for Cracker Barrel in recent weeks, and we've listened, switching back to our 'Old Timer' logo, hitting pause on remodels, and placing an even bigger emphasis in the kitchen and othe ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Prestige Consumer Healthcare Inc. stands amongst them. Prestige Consumer Healthcare Inc. (NYSE:PBH), a global developer of OTC health and personal care products, is taking strategic steps to secure growth in its eye care business amid operational challenges in 2025. In August 2025, Prestige Consumer Healthcare Inc. (NYSE:PBH) acquired Pillar5 Pharma, a key supplier of multi-dose sterile ophthalmic products ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics, continues to advance its product portfolio and market presence in 2025. A key growth driver is its droplet digital PCR (ddPCR) platform, led by the QX600 system. The company recently acquired Stilla Technologies to enhance ddPCR capabilities and enter new ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Haemonetics Corporation is one of them. Haemonetics Corporation (NYSE:HAE), a global leader in blood and plasma management technologies, continues to advance healthcare efficiency through innovative medical devices. In 2025, the company launched the PerQseal Elite vascular closure system, receiving European CE Mark approval. This fully bioresorbable, sutureless device is designed for large-bore vascular ac ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Soleno Therapeutics, Inc. is one of them. Soleno Therapeutics, Inc. (NASDAQ:SLNO) tops our list for being one of the most oversold stocks. It is a clinical-stage biotech focused on rare diseases and has seen significant stock volatility in 2025 following the commercial launch of its lead product, VYKAT XR, the first FDA-approved treatment for hyperphagia in Prader-Willi Syndrome (PWS). The therapy addresses ...

大宗交易情况 - 9月18日大宗交易平台发生4笔成交 合计成交量9.69万股 成交金额1153.11万元 成交价格均为119.00元 相对当日收盘价折价15.24% [2] - 4笔交易买方营业部分别为中信证券上海分公司 华泰证券广州云城东路营业部 长江证券北京百万庄大街营业部 东北证券太原桃园北路营业部 卖方营业部均为国泰海通证券无锡湖滨路营业部 [3] 股价表现与资金流向 - 当日收盘价140.40元 单日上涨20.00% 日换手率14.35% 成交额29.89亿元 [2] - 全天主力资金净流入3717.49万元 近5日累计上涨39.22% 近5日资金合计净流入2.55亿元 [2] 融资交易数据 - 最新融资余额6.34亿元 近5日增加1.99亿元 增幅达45.94% [3] 公司基本信息 - 公司全称无锡市德科立光电子技术股份有限公司 成立于2000年01月31日 注册资本15828.5329万人民币 [3]

大宗交易情况 - 9月18日大宗交易成交量22.00万股，成交金额715.00万元，成交价32.50元，较当日收盘价折价16.62% [2] - 买方为第一创业证券长沙分公司，卖方为方正证券长沙芙蓉中路营业部 [2] - 近3个月累计发生2笔大宗交易，合计成交金额1412.93万元 [2] 股价及资金表现 - 当日收盘价38.98元，下跌3.11%，日换手率1.79%，成交额1.10亿元 [2] - 当日主力资金净流入596.62万元 [2] - 近5日股价累计下跌7.08%，资金合计净流入1498.23万元 [2] 融资融券数据 - 最新融资余额8992.44万元 [2] - 近5日融资余额增加2429.36万元，增幅达37.02% [2]

大宗交易情况 - 9月18日大宗交易成交量238.10万股，成交金额5000.00万元，成交价21.00元，较当日收盘价溢价12.72% [2] - 买方为中信证券湖北分公司，卖方为万联证券黄石天津路证券营业部 [2][3] - 当日收盘价18.63元，下跌1.22%，日换手率1.95%，成交额3990.82万元 [2] 资金流向表现 - 全天主力资金净流入417.30万元，近5日累计净流入1113.04万元 [2] - 近5日股价累计下跌0.64% [2] - 融资余额9167.89万元，近5日增加780.97万元，增幅达9.31% [3] 公司基本信息 - 邦彦技术股份有限公司成立于2000年4月6日 [3] - 公司注册资本15222.5204万元人民币 [3]

大宗交易情况 - 9月18日发生一笔大宗交易成交量2.87万股，成交金额500.10万元，成交价174.25元较当日收盘价折价2.00% [2] - 买方为银泰证券西安友谊西路营业部，卖方为中信建投证券西安科技路营业部 [2] - 近3个月累计发生33笔大宗交易，合计成交金额达2.01亿元 [2] 股价表现与资金流向 - 当日收盘价177.81元，单日上涨1.05%，日换手率13.01% [2] - 当日成交额20.80亿元，主力资金净流出5807.30万元 [2] - 近5日累计上涨22.66%，期间资金净流入1608.86万元 [2] 融资交易数据 - 最新融资余额7.95亿元，近5日增加1.46亿元，增幅达22.49% [3]